Assertion: vasopressin | /r/CapableOf | show no mortality benefit
Facets:
Source sentences:
text: Finally, the Vasopressin vs. Norepinephrine as Initial therapy in Septic Shock (VANISH) trial also showed no mortality benefit from earlier vasopressin therapy (within six hours of shock recognition), although the primary outcome was focused on kidney failure-free days within a 28-day period after randomization.10